IDiyas

For the Inventor, By the Inventor

Tsuzuki, Japan

Katsuhiro Imaki

USPTO Granted Patents = 23

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 82(Granted Patents)


Location History:

  • Tsuzukigun, JP (1985)
  • Kyoto, JP (1987 - 1993)
  • Tsuzuki, JP (1984 - 1994)
  • Osaka, JP (1991 - 1998)

Company Filing History:

goldMedal23 out of 574 
 
Ono Pharmaceutical Co., Ltd.
 patents

Years Active: 1984-1998

Loading Chart...
23 patents (USPTO):Explore Patents
1. 5733927 - Salts of glucopyranose derivative and solutions of the same (1998-03-31),
2. 5403850 - Derivatives of P-substituted phenyl ester of pivalic acid (1995-04-04),
3. 5376655 - Derivatives of p-guanidinobenzoic acid and pharmaceutical agents (1994-12-27),
4. 5359121 - Glycine derivative monosodium salt tetrahydrate (1994-10-25),
5. 5336681 - Derivatives of p-substituted phenyl ester of pivalic acid (1994-08-09),
6. 5294723 - Salts of glucopyranose derivatives and its intermediate (1994-03-15),
7. 5247084 - Derivatives of p-guanidinobenzoic acid (1993-09-21),
8. 5221689 - Prostaglandin analogues, processes for their preparation and (1993-06-22),
9. 5109021 - Prostaglandin analogues, process for their preparation and (1992-04-28),
10. 5077428 - Pharmacologically active derivatives of p-guanidinobenzoic acid (1991-12-31),
11. 5023268 - 3-phenoxy (or phenylthio)-cyclopentanecarbonylamino acid analogues (1991-06-11),
12. 5017610 - Derivatives of p-substituted phenyl ester of pivalic acid (1991-05-21),
13. 4935446 - Prostaglandin analogues, process for their preparation and (1990-06-19),
14. 4916147 - 3-[(4-Aroyl) phenoxy (or phenylthio)]-cyclopentanecarboxylic acid (1990-04-10),
15. 4888351 - 3-phenoxy (or phenylthia) cyclopentanecarbonylamino acid analogues (1989-12-19),

Title: Katsuhiro Imaki: A Pioneer in Immunology and Pharmaceutical Innovations

Introduction: Katsuhiro Imaki, based in Tsuzuki, Japan, is a prominent inventor with an impressive portfolio of 23 patents. His work primarily revolves around the enhancement of cellular immunity and the development of pharmaceutical compounds that demonstrate significant therapeutic potential.

Latest Patents: Among his latest inventions, Imaki has developed innovative methods for improving the solubility of glucopyranose derivative salts. These compounds not only enhance cellular immunity but also exhibit anti-tumor properties by inducing essential cytokines such as TNF, IL-1, and IFN. Additionally, another noteworthy patent includes a derivative of P-substituted phenyl ester of pivalic acid, which shows inhibitory activity on elastase. This derivative is particularly beneficial for treating conditions such as pulmonary emphysema, atherosclerosis, and rheumatoid arthritis.

Career Highlights: Katsuhiro Imaki is an esteemed researcher working with Ono Pharmaceutical Co., Ltd., where his contributions to the field of pharmaceuticals have been significant. His innovations not only reflect his deep understanding of biochemical interactions but also his commitment to improving human health through scientific advancements.

Collaborations: Imaki collaborates with notable colleagues including Yoshinobu Arai and Tadao Okegawa. Together, they have contributed to the development of groundbreaking therapies and continue to push the boundaries of pharmaceutical research.

Conclusion: Katsuhiro Imaki stands as a distinguished inventor in the realm of immunology and pharmaceutical innovations. His patents demonstrate a blend of creativity and scientific rigor, aimed at addressing critical health issues. With ongoing collaborations and a continuous drive for invention, Imaki's work is likely to remain influential in the pharmaceutical field for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…